163 related articles for article (PubMed ID: 21188534)
1. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.
Lin F; Li Y; Cao J; Fan S; Wen J; Zhu G; Du H; Liang Y
Mol Biol Rep; 2011 Nov; 38(8):5205-10. PubMed ID: 21188534
[TBL] [Abstract][Full Text] [Related]
2. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
3. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
[TBL] [Abstract][Full Text] [Related]
4. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
[TBL] [Abstract][Full Text] [Related]
5. Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.
Lin F; Huang CM; Cao J; Pei ZH; Gu WL; Fan SF; Li KP; Lin CM
Genet Mol Res; 2015 Nov; 14(4):14440-7. PubMed ID: 26600502
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
Chen RX; Xia YH; Xue TC; Ye SL
Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
[TBL] [Abstract][Full Text] [Related]
7. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
8. Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.
Wu JC; Sun BS; Ren N; Ye QH; Qin LX
J Cancer Res Clin Oncol; 2010 Apr; 136(4):595-601. PubMed ID: 19834740
[TBL] [Abstract][Full Text] [Related]
9. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
[TBL] [Abstract][Full Text] [Related]
10. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
13. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
Bhattacharya SD; Garrison J; Guo H; Mi Z; Markovic J; Kim VM; Kuo PC
Surgery; 2010 Aug; 148(2):291-7. PubMed ID: 20576283
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression.
Chen RX; Xia YH; Xue TC; Ye SL
J Exp Clin Cancer Res; 2010 Dec; 29(1):172. PubMed ID: 21190594
[TBL] [Abstract][Full Text] [Related]
15. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
[TBL] [Abstract][Full Text] [Related]
16. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
Emani S; Zhang J; Guo L; Guo H; Kuo PC
Surgery; 2008 Jun; 143(6):803-12. PubMed ID: 18549897
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of osteopontin in hepatocellular carcinoma.
Gotoh M; Sakamoto M; Kanetaka K; Chuuma M; Hirohashi S
Pathol Int; 2002 Jan; 52(1):19-24. PubMed ID: 11940202
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.
Iqbal J; McRae S; Banaudha K; Mai T; Waris G
J Biol Chem; 2013 Dec; 288(52):36994-7009. PubMed ID: 24240095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
